BioAlliance Pharma SA announced that its Shareholders adopted all the resolutions supported by its Board of Directors. The Shareholders appointed Thomas Hofstaetter as independent Board Member, increasing thus the number of independent members to 5 out of a total of 8.
Besides, due to internal organization changes,ING Belgium, represented by Luc Van de Steen, has announced at the last Board meeting of BioAlliance Pharma its wish to resign from its Board member mandate.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.